Arvind Manor Dsij / Thursday, January 11, 2018 / Categories: Flash News Investment App, Reco - Fundamentals Recommendations Indraprastha Medical Corporation Ticker : 532150 BUY: Rs.64 Target: Rs.76 IMCL in a joint set-up with Apollo Hospitals Group offering wide range of latest medical treatments at affordable prices. The company follows asset-light model with return ratios like ROE and ROCE in range of 12 per cent and 17 per cent, respectively. It is a well-established brand in New Delhi, while the Apollo group has a strong presence in the South Asian region. It has introduced many cutting-edge technologies and new services to serve the cancer patients and has specialisation in neurology. It has also started new services that include geriatric services, laboratory services, physiotherapy and cardiology, which are gaining confidence among patients and building its brand. The healthcare sector was going through a low phase, but a revival is expected to be seen going forward. We recommend it as a BUY. Previous Article Corporate Earnings May Come As Breather In The Near Term Next Article Watch out for these sectoral funds in 2018 Print 334 Rate this article: No rating Please login or register to post comments.